1. Home
  2. CR vs HIMS Comparison

CR vs HIMS Comparison

Compare CR & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CR
  • HIMS
  • Stock Information
  • Founded
  • CR 1855
  • HIMS 2017
  • Country
  • CR United States
  • HIMS United States
  • Employees
  • CR N/A
  • HIMS N/A
  • Industry
  • CR Metal Fabrications
  • HIMS Medical/Nursing Services
  • Sector
  • CR Industrials
  • HIMS Health Care
  • Exchange
  • CR Nasdaq
  • HIMS Nasdaq
  • Market Cap
  • CR 10.4B
  • HIMS 12.2B
  • IPO Year
  • CR N/A
  • HIMS N/A
  • Fundamental
  • Price
  • CR $185.53
  • HIMS $47.26
  • Analyst Decision
  • CR Strong Buy
  • HIMS Hold
  • Analyst Count
  • CR 5
  • HIMS 12
  • Target Price
  • CR $222.20
  • HIMS $37.20
  • AVG Volume (30 Days)
  • CR 252.9K
  • HIMS 31.2M
  • Earning Date
  • CR 10-27-2025
  • HIMS 11-03-2025
  • Dividend Yield
  • CR 0.50%
  • HIMS N/A
  • EPS Growth
  • CR 44.57
  • HIMS 866.21
  • EPS
  • CR 6.02
  • HIMS 0.79
  • Revenue
  • CR $2,227,200,000.00
  • HIMS $2,013,538,000.00
  • Revenue This Year
  • CR $10.69
  • HIMS $61.66
  • Revenue Next Year
  • CR $10.98
  • HIMS $19.48
  • P/E Ratio
  • CR $30.68
  • HIMS $60.17
  • Revenue Growth
  • CR 18.63
  • HIMS 88.69
  • 52 Week Low
  • CR $127.04
  • HIMS $18.33
  • 52 Week High
  • CR $203.89
  • HIMS $72.98
  • Technical
  • Relative Strength Index (RSI)
  • CR 55.10
  • HIMS 40.30
  • Support Level
  • CR $175.03
  • HIMS $49.73
  • Resistance Level
  • CR $182.76
  • HIMS $65.30
  • Average True Range (ATR)
  • CR 4.33
  • HIMS 4.44
  • MACD
  • CR 1.17
  • HIMS -1.25
  • Stochastic Oscillator
  • CR 70.14
  • HIMS 5.80

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.

About HIMS Hims & Hers Health Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Share on Social Networks: